FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

385275000: forme pharmaceutique pour usage transdermique et/ou cutané (valeur de l'attribut)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    436351000077118 forme pharmaceutique pour usage transdermique et/ou cutané (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form est un(e) (attribut) type de préparation médicamenteuse false Inferred relationship Some
    Cutaneous AND/OR transdermal dosage form est un(e) (attribut) Dose form by site prepared for false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Coal tar extract 2% shampoo (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Selenium sulfide 25 mg/mL shampoo a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Alcoholic coal tar extract 5% shampoo (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 43 mg/mL shampoo a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Lithium succinate 80 mg/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely lithium succinate 80 milligram/1 milliliter conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Chloramphenicol DTF 1% cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Colistin sulfate topical powder (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Mupirocin (as mupirocin calcium) 20 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Neomycin 0.5% cream BPC (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Silver sulfadiazine 1% cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Fusidic acid 20 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sodium fusidate 20 mg/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Betamethasone+clotrimazole 0.05/1% cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous spray (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Clotrimazole 1% dusting powder (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Econazole nitrate 10 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Ketoconazole 20 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Miconazole nitrate 20 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Miconazole nitrate 2% dusting powder (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Nystatin 100000 unit/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Nystatin 100000 unit/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sulconazole nitrate 10 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Undecylenic acid 50 mg/mL and zinc undecylenate 200 mg/mL cutaneous spray a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Metronidazole 10 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Amorolfine 5% nail lacquer (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Amorolfine (as amorolfine hydrochloride) 2.5 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Acyclovir 50 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Penciclovir 10 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzyl benzoate 25% application BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Carbaryl 0.5% alcoholic lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Malathion 1% cream shampoo (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Malathion 0.5% alcoholic lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Malathion 0.5% liquid (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Malathion 10 mg/mL shampoo a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Phenothrin 0.5% liquid (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely phenothrin 5 milligram/1 gram conventional release cutaneous foam (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Permethrin 1% scalp application (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Chlorhexidine 5% cream BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Proflavine cream BPC (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone iodine 50 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Polynoxylin 100 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Magnesium sulfate paste BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone iodine 100 mg/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely aluminium acetate 6.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzalkonium chloride 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Cetrimide 10 mg/mL cutaneous solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Cetrimide strong 20% solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Cetrimide strong 40% solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Chlorhexidine acetate 1% dusting powder (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Chlorhexidine gluconate+cetrimide 1.5%/15% topical liquid sachet (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Chlorhexidine gluconate+cetrimide 0.015%/0.15% topical liquid sachet (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sodium hypochlorite strong 8% solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sodium hypochlorite weak 1% solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sodium hypochlorite topical liquid sachet (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Brilliant green+crystal violet 0.5%/0.5% paint BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Crystal violet 0.5% paint BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Gentian violet 10 mg/mL cutaneous solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Hydrogen peroxide 6%(20volume) solution BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Hydrogen peroxide 12%(40volume) solution BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Hydrogen peroxide 30%(100volume) solution BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone-iodine 1.14% dry powder spray (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone-iodine 7.5% surgical scrub (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone-iodine 4% skin cleanser solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone-iodine 2.5% dry powder spray (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone-iodine antiseptic 10% solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone-iodine alcoholic 10% solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Povidone-iodine 10% paint (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Silver nitrate 0.5% lotion BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Silver nitrate 250 mg/mL cutaneous solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Silver nitrate 500 mg/mL cutaneous solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some

    Start Previous Page 5 of 13 Next End


    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start